10. Daftar Pustaka - Dr.lucy

8/16/2019 10. Daftar Pustaka - Dr.lucy

http://slidepdf.com/reader/full/10-daftar-pustaka-drlucy 1/6

43

DAFTAR PUSTAKA

1. Suleiman M, Hammerman H, Boulos M. Fasting glucose is an important

independent risk factor for 30-day mortality in patients wit acute myocardial

infarction! a prospecti"e study. #irculation $00%&111! '%(-)0.

$. *immer +, an der Horst #, tter"anger + et al . rognostic "alue of

admission glucose in non-dia/etic patients wit myocardial infarction. m

Heart + $00(&1(!322-(0(.3. Brunkorst F, ngel #, Bloos F. 4ntensi"e insulin terapy and pentastarc

resuscitation in se"ere sepsis. 5 ngl + Med $00&3%!1$%-32.

(. 4apicino 6, l/icini M, 7m/rello M. *igt glycemic control does not affect

asymmetric dimetylarginine in septic patients. 4ntensi"e #are Med

$00&3(!1(3-%0.

%. 8aird , Miller , 9ilgo . :elationsip of early yperglycemia to mortality in

trauma patients. + *rauma $00(&%)!10%-)$.

). an den Berge 6, ;outers , ;eekers F et al. 4ntensi"e insulin terapy in

te critically ill patients. 5 ngl + Med $001&3(%! 13%2-)'.

'. ;iener :, ;iener <, 8arson :. Benefits and :isks of *igt 6lucose #ontrol

in #ritically 4ll dults! a meta-analysis. +M $00&300!233-((.

. Mitcell 4, 9nigt , 6issane + et al. pase 44 randomised controlled trial of

intensi"e insulin terapy in general intensi"e care patients. #rit #are :esusc

$00)&!$2-23.

2. 54#-S76: Study 4n"estigators. 4ntensi"e "ersus con"entional insulin

terapy in critically ill patients. 5 ngl + Med $002&3)0!1$3-2'.

10. li 5, =Brien +M, Blum ;. Hyperglycemia in patients wit acute myeloid

leukemia is associated wit increased ospital mortality. #ancer $00'&110!2)-

10$.



44

11. 8acerade +, +ac>ueminet S, reiser +. n o"er"iew of ypoglycaemia in te

critically ill. + <ia/etes Sci *ecnol $002&3!1$($-(2.1$. gi M, Bellomo :, Stacowski et al. Hypoglycemia and outcome in te

critically ill patients. Mayo #lin roc $010&%!$1'-$(.

13. lank +, Blaa +, #ordingley +, ;ilinska M, #assin 8+, Morgan #, S>uire

S, Halu?ik M, 9remen +, S"acina S, *oller ;, lasnik , llmerer M,

Ho"orka :, ie/er *:. Multicentric, randomi?ed, controlled trial to e"aluate

/lood glucose control /y te model predicti"e control algoritm "ersus

routine glucose management protocols in intensi"e care unit patients @8etterA.

<ia/etes #are $2!12'12, $00).

1(. an den Berge 6, ;outers , ;eekers F, erwaest #, BruyninckC F, Scet?

M, lasselaers <, Ferdinande , 8auwers , Bouillon :. 4ntensi"e insulin

terapy in te critically ill patients. 5 ngl + Med 3(%! 13%213)', $001.

1%. <e Block #, Manuel D9B, an 6aal 8, :ogiers . 4ntensi"e insulin terapy

in te intensi"e care unit! assessment /y continuous glucose monitoring.

<ia/etes #are. $2!1'%01'%), $00).

1). Barseset , 6arty M, 6rossman , et al. dmission /lood glucose le"el

and mortality among ospitali?ed nondia/etic patients wit eart failure. rc

4ntern Med $00)&1))@1%A!1)131)12.Eu/Med! 1)20'2(.

1'. Bociccio 6, Sung +, +osi M, et al. ersistent yperglycemia is predicti"e

of outcome in critically ill trauma patients. + *rauma $00%&%@%A!2$12$(.

Eu/Med! 1%2$0(0(.

1. #apes S, Hunt <, Malm/erg 9, et al . Stress yperglycaemia and increased

risk of deat after myocardial infarction in patients wit and witout dia/etes!

a systematic o"er"iew. 8ancet $000&3%%@2$0)A!''3''. Eu/Med!

10'112$3.



45

12. Finney S+, Gek"eld #, lia , et al . 6lucose control and mortality in critically

ill patients. +M $003&$20@1%A!$0(1$0('. Eu/Med! 1(%%22%.$0. 6olden SH, eart-igilance #, 9ao ;H, et al . erioperati"e glycemic control

and te risk of infectious complications in a coort of adults wit dia/etes.

<ia/etes #are 1222&$$@2A!1(01(1(. Eu/Med! 10(0%01.

$1. :eed ##, Stewart :M, Serman M, et al . 4ntensi"e insulin protocol impro"es

glucose control and is associated wit a reduction in intensi"e care unit

mortality. +ournal of te merican #ollege of Surgeons $00'&$0(@%A!10(

10%(. discussion 10%(-10(%. Eu/Med! 1'(1%3.

$$. lasselaers <, Milants 4, <esmet 8, et al . 4ntensi"e insulin terapy for

patients in paediatric intensi"e care! a prospecti"e, randomised controlled

study. 8ancet. $002.

$3. Brunkorst FM, ngel #, Bloos F, et al . 4ntensi"e insulin terapy and

pentastarc resuscitation in se"ere sepsis. 5 ngl + Med $00&3%@$A!1$%

132. Eu/Med! 11(2%.

$(. ra/i DM, <a//ag #, *amim HM, et al . 4ntensi"e "ersus con"entional

insulin terapy! a randomi?ed controlled trial in medical and surgical

critically ill patients. #ritical care medicine $00&3)@1$A!3120312'.

Eu/Med! 123)'0$.

$%. Finfer S, #ittock <:, Su SD, et al . 4ntensi"e "ersus con"entional glucose

control in critically ill patients. 5 ngl + Med $002&3)0@13A!1$31$2'.

Eu/Med! 12313(.

$). 9osi/orod M, 4n?ucci S, 9rumol? HM, et al . 6lucometrics in patients

ospitali?ed wit acute myocardial infarction! defining te optimal outcomes-

/ased measure of risk. #irculation $00&11'@A!10110$'. Eu/Med!

1$)1(%.



46

$'. #lement S, Braitwaite SS, Magee MF, et al . Management of dia/etes and

yperglycemia in ospitals. <ia/etes #are $00(&$'@$A!%%3%2'. Eu/Med!

1('('$(3.

$. 6ar/er +, Mogissi S, Bransome < +r. et al. merican #ollege of

ndocrinology position statement on inpatient dia/etes and meta/olic control.

ndocr ract $00(&10@Suppl $A!(2.Eu/Med! 1%$%1)33.

$2. :ady MD, +onson <+, atel BM, et al . 4nfluence of indi"idual caracteristics

on outcome of glycemic control in intensi"e care unit patients wit or witout

dia/etes mellitus. Mayo #lin roc $00%&0@1$A!1%%1%)'. Eu/Med!

1)3($)(.

30. Hafid S, :euter M<, #assels 8+, et al. ffect of intra"enous insulin

terapy on clinical outcomes in critically ill patients. *e merican ournal of

te medical sciences $00'&333@)A!3%(3)1. Eu/Med! 1'%'02.

31. Malotra . 4ntensi"e insulin in intensi"e care. 5 ngl + Med

$00)&3%(@%A!%1)%1. Eu/Med!1)(%$%)(.

3$. Herpe *, Mesotten <. Blood glucose measurements in critically ill patients.

+ <ia/etes Science and *ecnology. $01$&)!$$-$.

33. Bagsaw SM, gi M, 6eorge #, Bellomo :& ustralia 5ew Gealend 4ntensi"e

#are Society <ata/ase Management #ommittee. arly /lood glucose control

and mortality in critically ill patients in ustralia. #rit #are Med.

$002&3'@$A!()3'0.3(. #em/rowski 6S, *ran <, Slater-Maclean 8, #in <, 6i/ney :*, +acka M.

#ould suscepti/ility to low ematocrit interference a"e compromised te

results of te 54#-S76: trialI #lin #em. $010&%)@'A!1123%.

3%. 8yon M, <uBois +, Fick 6H, 8yon ;. stimates of total analytical error

in consumer and ospital glucose meters contri/uted /y ematocrit, maltose,

and ascor/ate. + <ia/etes Sci *ecnol. $010&(@)A!1('22(.



47

3). 5g ;D, *iong ##, +aco/ . Maltose interference-free test strips for /lood

glucose testing at point-of-care! a la/oratory performance e"aluation.

<ia/etes *ecnol *er. $010&1$@11A!223.

3'. Hol?inger 7, ;ars?awska +, 9it?/erger :, ;ewalka ;, Herkner H, Madl #.

:eal-time continuous glucose monitoring in critically ill patients! a

prospecti"e randomi?ed trial. <ia/etes #are. $010&33@3A!()''$.

3. radian . *e ffect of deCtrose to /lood of 6lukosa and ketone /odies le"el

in pediatric atient underwent la/ioplasty. *e 4ndonesian +ournal of

anestesiology and #ritical #are, Bandung& $00(! 102-11'.

32. ;aCman 9. ysiologic respon to inury. 4n ! soemaker ;#, Hol/rook :,

yres SM, 6ren"ik . #ritical #are. ;.B.Saunders #ompany, iladelpia,

8ondon, *oronto, $000! $''-$.

(0. Faustino , pon M. ersistent yperglycemia in critically ill cildren. +

ediatr $00%&1()!30-(.

(1. Dung M, ;ilkins B, 5orton 8. 6lucose control, organ failure, and mortality

in pediatric intensi"e care. ediatr #rit #are Med $00&2!1('-%$.

($. Branco :.6, 6arcia .#.:, i"a +.. 6lucose le"el and risk of mortality in

pediatric sepstic sock. ediatr #rit #are Med $00%& )! ('0-$.

(3. Dung M, ;ilkins B, 5orton 8 6lucose control, organ failure, and mortality in

pediatric intensi"e care. ediatr #rit #are Med $00&2!1('-%$.

((. Srini"asan , Spinella #, <rott H:. ssociation of timing, duration,and

intensity of yperglycemia witintensi"e care unit mortality ill cildren.

ediatr #rit #are Med $00(& %! 3$2-3).

(%. 8eteurtre S, Martinot , <uamel , roulC F, 6ran/astien B, #otting +,

6ottesman :, dkk. alidation of te paediatric logistic organ dysfunction

@8<A score! prospecti"e, o/ser"ational, multicentre study. 8ancet $003&

3)$!12$-'.



48

(). scallon +. #ar/oydrates, proteins and lipids dalam Mc#arnis M et al,

editors. n integrated approac to patient care total nutritional terapy. $ nd

ed. ennsyl"ania! lse"ier& $003.p.%1-)1.

('. ;iener :S, ;iener <#, 8arson :+. Benefits and risks of tigt glucose control

in critically ill adults. +M $00&300!233 ((.

(. Boyd +#, Bruns <. Juality specifications for glucose meters! assessment /y

simulation modeling of errors in insulin dose. #lin #em $001& ('!$02 1(.

(2. 9im/erly MM, esper H;, #audill S, et al . aria/ility among fi"e o"er-te-

counter /lood glucose monitors. #lin #im cta $00)&3)(!$2$'.50.9rouwer +S, #em/rowski 6S. re"iew of standards and statistics used to

descri/e /lood glucose monitor performance. + <ia/etes Sci *ecnol.

$010&(@1A!'%3.

10. Daftar Pustaka - Dr.lucy

Documents

Transcript of 10. Daftar Pustaka - Dr.lucy